切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2018, Vol. 14 ›› Issue (02) : 186 -192. doi: 10.3877/cma.j.issn.1673-5250.2018.02.010

所属专题: 文献

论著

3个月龄以内婴儿败血症病原菌分布及抗菌药物耐药状况分析
徐晓明1, 付捷1, 高坎坎1, 朱素菲1, 曾兰兰1, 庄晓旭1, 高秀蓉1, 高飞1, 龙燕1, 刘海英1,()   
  1. 1. 510623 广州医科大学附属广州市妇女儿童医疗中心检验科
  • 收稿日期:2017-12-18 修回日期:2018-03-05 出版日期:2018-04-01
  • 通信作者: 刘海英

Pathogen distribution and antibiotic resistance in infants with sepsis up to the age of 3 months

Xiaoming Xu1, Jie Fu1, Kankan Gao1, Sufei Zhu1, Lanlan Zeng1, Xiaoxu Zhuang1, Xiurong Gao1, Fei Gao1, Yan Long1, Haiying Liu1,()   

  1. 1. Department of Clinical Laboratory, Guangzhou Women and Children′s Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong Province, China
  • Received:2017-12-18 Revised:2018-03-05 Published:2018-04-01
  • Corresponding author: Haiying Liu
  • About author:
    Corresponding author: Liu Haiying, Email:
引用本文:

徐晓明, 付捷, 高坎坎, 朱素菲, 曾兰兰, 庄晓旭, 高秀蓉, 高飞, 龙燕, 刘海英. 3个月龄以内婴儿败血症病原菌分布及抗菌药物耐药状况分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2018, 14(02): 186-192.

Xiaoming Xu, Jie Fu, Kankan Gao, Sufei Zhu, Lanlan Zeng, Xiaoxu Zhuang, Xiurong Gao, Fei Gao, Yan Long, Haiying Liu. Pathogen distribution and antibiotic resistance in infants with sepsis up to the age of 3 months[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2018, 14(02): 186-192.

目的

探讨月龄<3个月婴儿败血症的病原菌分布[排除凝固酶阴性葡萄球菌(CNS)]及其对抗菌药物耐药状况。

方法

选择2012年1月1日至2016年12月31日,广州医科大学附属广州市妇女儿童医疗中心收治的924例月龄<3个月的婴儿败血症患儿为研究对象。这924例患儿经血培养,共计分离出968株病原菌。回顾性分析924例月龄<3个月的婴儿败血症患儿的病原菌分布情况,早发型败血症(EOS)与晚发型败血症(LOS)患儿病原菌分布情况,以及常见革兰阴性杆菌、革兰阳性球菌对抗菌药物耐药情况。采用χ2检验,对EOS和LOS患儿血培养分离出的大肠埃希菌、肺炎克雷伯菌、B族链球菌(GBS)、金黄色葡萄球菌、真菌所占比例进行比较。本研究遵循的程序符合广州医科大学附属广州市妇女儿童医疗中心医学伦理委员会制定的伦理学标准,并得到该委员会审查批准。

结果

①本研究924例月龄<3个月的婴儿败血症患儿血培养共计分离出968株病原菌,其中革兰阴性杆菌为593株(61.3%,593/968),以大肠埃希菌(21.4%,207/968),肺炎克雷伯菌(19.6%,190/968)为主;革兰阳性球菌为318株(32.9%,318/968),以GBS(11.5%,111/968),金黄色葡萄球菌(7.7%,75/968),粪肠球菌(4.1%,40/968)为主;真菌为52株(5.4%,52/968);革兰阴性球菌为3株(0.3%,3/968);革兰阳性杆菌为2株(0.2%,2/968)。②197例EOS患儿血培养共计分离出226株病原菌,常见病原菌前3位依次为大肠埃希菌(23.9%,54/226),GBS(17.7%,40/226)和肺炎克雷伯菌(15.9%,36/226)。727例LOS患儿血培养共计分离出742株病原菌,常见病原菌前3位依次为肺炎克雷伯菌(20.8%,154/742),大肠埃希菌(20.6%, 153/742)和GBS(9.6%,71/742)。EOS患儿血培养分离出的GBS所占比例为17.7%(40/226),明显高于LOS患儿的9.6%(71/742),二者比较,差异有统计学意义(χ2=11.280,P=0.001)。EOS患儿血培养分离出的金黄色葡萄球菌及真菌所占比例分别为4.0%(9/226)与2.7%(6/226),均分别低于LOS患儿的8.9%(66/742)与6.2%(46/742),并且差异亦均有统计学意义(χ2=5.849,P=0.016;χ2=4.282,P=0.039)。③593株革兰阴性杆菌中,大肠埃希菌和肺炎克雷伯菌对氨苄西林耐药率均为最高,分别为81.1%和99.4%;对哌拉西林/他唑巴坦、阿米卡星、厄他培南、亚胺培南、头孢吡肟耐药率较低,为0~17.2%。④318株革兰阳性球菌中,GBS、金黄色葡萄球菌、粪肠球菌、屎肠球菌对万古霉素、替加环素、利奈唑烷的敏感性较高,耐药率均为0;金黄色葡萄球菌对青霉素G耐药率高达92.9%。

结论

革兰阴性杆菌是月龄<3个月婴儿败血症患儿的主要病原菌,其次是革兰阳性球菌。临床经验性选择抗菌药物治疗月龄<3个月婴儿败血症患儿时,应高度注意病原菌耐药问题。

Objective

To investigate the pathogen distribution with coagulase negative staphylococcus (CNS) excluded and antibiotic resistance of infants with sepsis during the first 3 months after birth.

Methods

A retrospective analysis was conducted on 968 isolates from 924 infants within 3 months of age who were admitted to the Guangzhou Women and Children′s Medical Center, Guangzhou Medical University from January 1, 2012 to December 31, 2016. The following items were analyzed, including pathogen distribution of 968 isolates from 924 infants within 3 months of age and with blood culture-confirmed sepsis, pathogen distribution of early-onset sepsis (EOS) infants and late-onset sepsis (LOS) infant, and antibiotic resistance of common Gram-negative bacilli and Gram-positive cocci. Chi-square test was taken to compare the constituent ratio of Escherichia coli, Klebsiella pneumoniae, group B streptococci (GBS), Staphylococcus aureus, and fungi isolated from blood culture-confirmed sepsis between EOS and LOS infants. The procedures followed in this study were in line with the ethical standards established by the Medical Ethics Committee of the Guangzhou Women and Children′s Medical Center, Guangzhou Medical University and were reviewed and approved by the committee.

Results

①Among 968 isolates from 924 infants within 3 months of age, Gram-negative bacilli were predominant (593 strains, 61.3%, 593/968), followed by Gram-positive cocci (318 strains, 32.9%, 318/968), fungi (52 strains, 5.4%, 52/968), Gram-negative cocci (3 strains, 0.3%, 3/968) and Gram-positive bacilli (2 strains, 0.2%, 2/968). Escherichia coli (21.4%, 207/968) and Klebsiella pneumoniae (19.6%, 190/968) were the main pathogens of Gram-negative bacilli. And GBS (11.5%, 111/968), Staphylococcus aureus (7.7%, 75/968), Enterococcus faecalis (4.1%, 40/968) were the main pathogens of Gram-positive cocci. ②A total of 226 isolates were isolated from 197 EOS infants, of which the predominant pathogens were Escherichia coli (23.9%, 54/226), GBS (17.7%, 40/226) and Klebsiella pneumoniae (15.9%, 36/226). Besides, a total of 742 isolates were isolated from 727 LOS infants, of which the predominant pathogens were Klebsiella pneumoniae (20.8%, 154/742), Escherichia coli (20.6%, 153/742), and GBS (9.6%, 71/742). The proportion of GBS in 226 isolates from EOS infants was 17.7% (40/226), which was significantly higher than that of the LOS infants (9.6%, 71/742), and the difference was statistically significant (χ2=11.28, P=0.001), whereas the proportion of Staphylococcus aureus and fungi in EOS infants were 4.0% (9/226) and 2.7% (6/226), respectively, which both were lower than those of LOS infants 8.9% (66/742) and 6.2% (46/742), respectively, and both the differences were also statistically significant (χ2=5.85, P=0.016; χ2=4.28, P=0.039). ③ Among 593 strains of Gram-negative bacilli, Escherichia coli and Klebsiella pneumoniae showed high resistance to ampicillin (81.1% and 99.4%), while low resistance to piperacillin/tazobactam, amikacin, ertapenem, imipenem and cefepime with the rate of resistance ranged from 0 to 17.2%. ④ Among 318 strains of Gram-positive cocci, GBS, Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium were highly sensitive to vancomycin, tigecycline and linezolid and the rates of resistance all were 0. In addition, Staphylococcus aureus showed high resistance to penicillin, and the rate of resistance was 92.9%.

Conclusions

Gram-negative bacilli is the main pathogen among infants with sepsis up to the age of 3 months, followed by Gram-positive cocci. Selection of anti-bacterial agents for the treatment of infants with sepsis up to the age of 3 months should be highly aware of drug resistance.

表1 924例月龄<3个月的婴儿败血症患儿血培养分离出的968株病原菌分布情况[株(%)]
表2 月龄<3个月的早发型与晚发型败血症患儿病原菌分布比较[株(%)]
表3 大肠埃希菌和肺炎雷伯菌这2种常见革兰阴性杆菌对抗菌药物的耐药率[%(n/n′)]
表4 4种常见革兰阳性球菌对抗菌药物的耐药率[%(n/n′)]
[1]
江载芳,申昆玲,沈颖. 诸福棠实用儿科学[M]. 8版. 北京: 人民卫生出版社, 2015, 491.
[2]
张国雄,胡雨婷,古汉福. 新生儿败血症病原菌分布及耐药性分析[J]. 国际检验医学杂志, 2012, 33(21): 2616-2617.
[3]
曹慧春,彭华保. 新生儿败血症病原学分布及耐药性分析[J]. 中国新生儿科杂志, 2016, 31(5): 353-356.
[4]
刘瑜,王琍琍,曹秀菁. 新生儿败血症病原菌及其耐药性六年的变迁[J]. 中国感染控制杂志, 2016, 15 (8) : 537-541.
[5]
中华医学会儿科学分会新生儿学组, 中华医学会中华儿科杂志编辑委员会. 新生儿败血症诊疗方案[J]. 中华儿科杂志, 2003, 41(12): 897-899.
[6]
中华医学会重症医学分会. 中国严重脓毒症/脓毒性休克治疗指南(2014)[J]. 中华内科杂志, 2015, 54(6): 557-581.
[7]
杨启文,王辉. 抗菌药物敏感性试验最新动向: 2010年CLSI M100-S20主要更新内容[J]. 中华检验医学杂志, 2010, 33(6): 488-491.
[8]
陈晓英,仇丽华,江倩男, 等. 不同病原菌新生儿败血症临床特点研究[J]. 中华新生儿科杂志, 2017, 32(2): 115-118.
[9]
李杨方,吴玉芹,奚敏, 等. 574例新生儿败血症病原菌及临床特征分析[J]. 中国小儿急救医学, 2013, 20(1): 85-87.
[10]
赵智,雷宏涛,刘合芳, 等. 新生儿败血症病原菌分布特点及耐药分析[J]. 中国妇幼健康研究, 2016, 27(3): 386-388.
[11]
杨婷婷. 新生儿败血症病原菌十年变迁及耐药现状的分析[J]. 中国医药指南, 2014, 12(29): 177-178.
[12]
吴茜,李杨方,吴玉芹, 等. 新生儿败血症近十年病原菌变迁及临床特征分析[J]. 中国小儿急救医学, 2013, 20(2): 190-192.
[13]
MarchantEA,BoyceGK,SadaranganiM, et al. Neonatal sepsis due to coagulase-negative staphylococci[J]. Clin Dev Immunol, 2013, 2013: 586076.
[14]
邓茂文,蔡强. 新生儿败血症病原学变迁及耐药性的临床研究[J]. 中国基层医药, 2015, 22(18): 2770-2773.
[15]
Mendoza-PalomarN,Balasch-CarullaM,González-Di LauroS, et al. Escherichia coli early-onset sepsis: trends over two decades [J]. Eur J Pediatr, 2017, 176(9): 1227-1234.
[16]
时春艳,曲首辉,杨磊, 等. 妊娠晚期孕妇B族链球菌带菌状况的检测及带菌对妊娠结局的影响[J]. 中华妇产科杂志, 2010, 45(1): 12-16.
[17]
关小珊,刘海英,钟华敏, 等. 广州地区低龄婴儿侵袭性B族链球菌的发病率及临床特征[J]. 中华实用儿科临床杂志, 2016, 31(10): 765-768.
[18]
VeraniJR,McGeeL,SchragSJ, et al. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010 [J]. MMWR Recomm Rep, 2010, 59 (RR-10): 1-36.
[19]
高坎坎,钟华敏,梁绮华, 等. B族链球菌相关疫苗的研究进展[J/CD]. 中华妇幼临床医学杂志(电子版), 2017, 13(1): 116-119.
[20]
ZinggW,PfisterR,Posfay-BarbeKM, et al. Secular trends in antibiotic use among neonates: 2001-2008 [J]. Pediatr Infect Dis J, 2011, 30(5): 365-370.
[21]
ArrietaAC,SheaK,DharV, et al. Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: a prospective, randomized, open-label, placebo-controlled pilot study [J]. Clin Ther, 2010, 32(2): 265-271.
[1] 庄燕, 戴林峰, 张海东, 陈秋华, 聂清芳. 脓毒症患者早期生存影响因素及Cox 风险预测模型构建[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 372-378.
[2] 杨瑾, 刘雪克, 张媛媛, 金钧, 韦瑶. 肠道微生物来源石胆酸对脓毒症相关肝损伤的保护作用[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 265-274.
[3] 张霞, 张瑞, 郑志波, 张勤. 紫草素调控乳酸化修饰和线粒体功能改善脓毒症心肌病小鼠的预后[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 275-284.
[4] 张婧琦, 江洋, 孙佳璐, 唐兴喆, 赵宇飞, 崔颖, 李信响, 戴景月, 傅琳, 彭新桂. 基于肾周CT特征结合血清肌酐水平探讨脓毒症伴急性肾损伤的早期识别[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 285-292.
[5] 李振翮, 魏长青, 甄国栋, 李振富. 脓毒症并发急性呼吸窘迫综合征患者血清S1P、Wnt5a变化及其临床意义[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 293-300.
[6] 费一鸣, 刘卓, 张丽娟. 组学分析在早产分子机制中的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 504-510.
[7] 徐婷婷, 詹泳池, 王晓东, 刘兴会. 电子胎心监测结果出现正弦波形的胎母输血综合征围生期结局分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 382-389.
[8] 邢嘉翌, 龚佳晟, 祝佳佳, 陆群. 肺癌化疗患者继发肺部感染的病原菌耐药性及炎症因子变化分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 714-718.
[9] 韦小霞, 陈管洁, 李雪珠, 李晓青, 钱淑媛. 机械通气患者抗菌药物雾化吸入的临床实施[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 334-337.
[10] 陈曦, 吴宗盛, 郑明珠, 邱海波. 胸腺萎缩在脓毒症免疫紊乱中的研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 379-383.
[11] 杨翔, 郭兰骐, 谢剑锋, 邱海波. 转录组学在脓毒症诊疗中的临床研究进展[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 384-388.
[12] 成人脓毒症患者β-内酰胺类抗生素延长输注专家共识编写组. 成人脓毒症患者β-内酰胺类抗生素延长输注专家共识[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 313-324.
[13] 陈惠英, 邱敏珊, 邵汉权. 脓毒症诱发肠黏膜屏障功能损伤的风险因素模型构建与应用效果[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 448-452.
[14] 李茂军, 唐彬秩, 吴青, 阳倩, 梁小明, 邹福兰, 黄蓉, 陈昌辉. 新生儿呼吸窘迫综合征的管理:多国指南/共识及RDS-NExT workshop 共识陈述简介和评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 607-617.
[15] 傅新露, 李之岳, 卢丹. 妊娠合并结肠癌穿孔致脓毒症休克一例并文献复习[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 227-231.
阅读次数
全文


摘要